Insider · CIK 0001405684
Philip Wagenheim
Files at IMNM (Immunome Inc.), SWMR (Swarmer, Inc). First filing Mar 23, 2026, latest Mar 23, 2026.
Philip Wagenheim files SEC Form 4 as director and 10% owner at IMNM (Immunome Inc.), and also at SWMR (Swarmer, Inc). Since Mar 23, 2026, Philip Wagenheim has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.3M, the latest filed on Mar 23, 2026.
A track record needs three past buys with six months of prices behind them; Philip Wagenheim has 0, so none is measured yet.
The newest scored trade: sold $1.3M of IMNM on Mar 20, 2026, filed Mar 23, 2026, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMNM: Immunome Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Immunome Inc. | $1.3M 65,000 shares | -16% | +260% from low-26% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | SWMR Swarmer, Inc | AGrant or award Stock Option (right to buy)derivative | +6,428 | $0.00 | $0 | 6,428 | 11 d ago |
| Sep 15, 2026 | SWMR Swarmer, Inc | JOther Common Stockindirect: Theseus Capital Partners, LLC | -1,124,981 | $0.00 | $0 | 0 | 26 d ago |
| Sep 16, 2026 | SWMR Swarmer, Inc | XIn-the-money exercise Common Stockindirect: Theseus Capital Partners, LLC | +819,487 | $3.33 | $2.7M | 819,487 | 26 d ago |
| Sep 16, 2026 | SWMR Swarmer, Inc | XIn-the-money exercise Warrantsderivativeindirect: Theseus Capital Partners, LLC | -899,988 | - | - | 0 | 26 d ago |
| Jun 10, 2026 | IMNM Immunome Inc. | AGrant or award Director Stock Option (right to buy)derivative | +9,897 | $0.00 | $0 | 9,897 | Jun 12, 2026 |
| Mar 20, 2026 | IMNM Immunome Inc. | SOpen-market sale Common Stock | -36,800 | $20.47 | $753k | 369,347 | Mar 23, 2026 |
| Mar 23, 2026 | IMNM Immunome Inc. | SOpen-market sale Common Stock | -28,200 | $20.65 | $582k | 341,147 | Mar 23, 2026 |
| Mar 18, 2026 | SWMR Swarmer, Inc | CConversion Common Stockindirect: Theseus Capital Partners, LLC | +1,124,981 | - | - | 1,124,981 | Mar 18, 2026 |
| Mar 18, 2026 | SWMR Swarmer, Inc | CConversion Series A-1 Preferred Stockderivativeindirect: Theseus Capital Partners, LLC | -597,980 | - | - | 0 | Mar 18, 2026 |
| Jun 10, 2025 | IMNM Immunome Inc. | AGrant or award Director Stock Option (right to buy)derivative | +18,864 | $0.00 | $0 | 18,864 | Jun 12, 2025 |
Questions about Philip Wagenheim
Answered from the filings on this page, as of the latest one.
Is Philip Wagenheim buying or selling?
In the last 12 months Philip Wagenheim reported 0 open-market buys worth $0 and 1 open-market sell worth $1.3M on SEC Form 4; the latest was sold $1.3M of IMNM on Mar 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Philip Wagenheim's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Philip Wagenheim has 0.
Where does Philip Wagenheim file Form 4?
Philip Wagenheim has filed Form 4 at IMNM (Immunome Inc.); SWMR (Swarmer, Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.